References
1. Biteker M, Altun I, Basaran O, Dogan V, Yildirim B, Ergun G (2015) Treatment of Prosthetic Valve Thrombosis: Current Evidence and Future Directions. J Clin Med Res. 7:932-936.
2. Dulgheru R, Lancellotti P, Dweck MR, Garbi M, Magne J, Nieman K, Rosenhek R, Bernard A, Lowenstein J, Vieira MLC, Rabischoffsky A, Vyhmeister RH, Zhou X, Zhang Y, Zamorano J-L, Habib G, Pibarot P, Chambers J, Edvardsen T, Delgado V, Pepi M, Cosyns B (2016) Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 17:589-590
3. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A (2017) 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 70:252-289.
4. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL; ESC Scientific Document Group (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 38 :2739-2791.
5. Kalçık M, Gürsoy OM, Astarcıoğlu MA, Özkan M (2014) A serial fluoroscopy-guided thrombolytic therapy of a mechanical tricuspid prosthetic valve thrombosis with low-dose and ultra-slow infusion of tissue-type plasminogen activator. Turk Kardiyol Dern Ars. 42:478-481.
6. Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalçık M, Oğuz AE, Gündüz S, Astarcioglu MA, Aykan AÇ, Bayram Z, Biteker M, Kaynak E, Kahveci G, Duran NE, Yıldız M (2013) Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator. Circulation. 128:532-540.
7. Özkan M, Gündüz S, Biteker M, Astarcioglu MA, Çevik C, Kaynak E, Yıldız M, Oğuz E, Aykan AÇ, Ertürk E, Karavelioğlu Y, Gökdeniz T, Kaya H, Gürsoy OM, Çakal B, Karakoyun S, Duran N, Özdemir N (2013) Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. JACC Cardiovasc Imaging. 6:206-216.
8. Zaghloul A, Iorgoveanu C, Desai A, Silkowski M and Balakumaran K (2018) Prosthetic Tricuspid Valve Thrombosis. Cureus. 10: e2928.
9. Huang G, Schaff HV, Sundt TM, Rahimtoola SH (2013) Treatment of obstructive thrombosed prosthetic heart valve. J Am Coll Cardiol. 62:1731-1736.
10. Liu P, Qiao WH, Sun FQ, Ruan XL, Al Shirbini M, Hu D, Chen S, Dong NG (2016) Should a Mechanical or Biological Prosthesis Be Used for a Tricuspid Valve Replacement? A Meta-Analysis. J Card Surg. 31:294-302.
11. Roudaut R, Serri K, Lafitte S (2007) Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart. 93:137-142.
12. Sensoy B, Canpolat U, Cay S, Ozeke O, Acikgoz K, Kus O, Tufekcioglu O (2015) Treatment of mechanical valve thrombosis in the right heart: overview of the requirements for the new thrombolytic protocols Blood Coagul Fibrinolysis. 26:220-222.
13. McElhinney DB, Cabalka AK, Aboulhosn JA, Eicken A, Boudjemline Y, Schubert S, Himbert D, Asnes JD, Salizzoni S, Bocks ML, Cheatham JP, Momenah TS, Kim DW, Schranz D, Meadows J, Thomson JD, Goldstein BH, Crittendon I 3rd, Fagan TE, Webb JG, Horlick E, Delaney JW, Jones TK, Shahanavaz S, Moretti C, Hainstock MR, Kenny DP, Berger F, Rihal CS, Dvir D (2016) Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves: An International, Multicenter Registry Study. Circulation. 133:1582-1593.
14. Taherkhani M, Hashemi SR, Hekmat M, Safi M, Taherkhani A, Movahed MR (2015) Thrombolytic Therapy for Right-Sided Mechanical Pulmonic and Tricuspid Valves: The Largest Survival Analysis to Date. Tex Heart Inst J. 42:543-547.
15. Shapira Y, Sagie A, Jortner R, Adler Y, Hirsch R (1999) Thrombosis of bileaflet tricuspid valve prosthesis: clinical spectrum and the role of nonsurgical treatment. Am Heart J. 137:721-725.
16. Zhang DY, Lozier J, Chang R, Sachdev V, Chen MY, Audibert JL, Horvath KA , Rosing DR (2012) Case study and review: treatment of tricuspid prosthetic valve thrombosis. Int J Cardiol. 162:14-19.
17. Panduranga P, Al-Mukhaini M, Al-Muslahi M, Haque MA, Shehab A (2012) Management dilemmas in patients with mechanical heart valves and warfarin-induced major bleeding World J Cardiol. 4: 54–59.
18. Roudaut R, Lafitte S, Roudaut MF, Reant P, Pillois X, Durrieu-Jais C, Coste P, Deville C, Roques X (2009) Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases. Arch Cardiovasc Dis. 102:269-277.
19. Separham A, Ghaffari S, Aslanabadi N, Sohrabi B, Ghojazadeh M, Anamzadeh E, Hajizadeh R, Davarmoin G (2015) Prosthetic valve thrombosis. J Card Surg. 30:246-50.
20. Marder VJ and Stewart D. Towards safer thrombolytic therapy (2002) Semin Hematol. 39:206-216.
21. Özkan M, Kalçık M, Gürsoy MO, Öcal L, Griffini S, Karakoyun S, Yesin M, Gündüz S, Astarcıoğlu MA, Bayam E, Cerşit S, Aykan AÇ, Cugno M (2016) Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial. J Cardiovasc Pharmacol Ther. 21:372-380.
22. Besir FH, Gul M, Ornek T, Ozer T, Ucan B, Kart L. (2011) Enoxaparin-associated giant retroperitoneal hematoma in pulmonary embolism treatment. N Am J Med Sci. 3:524-526.
23. Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, Aykan AÇ, Çakal B, Bayram 3, Oğuz AE, Ertürk E, Yesin M, Gökdeniz T, Duran N3, Yıldız M, Esen AM (2015) Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial. Am Heart J. 170: 409-418.
24. Yaminisharif A, Alemzadeh-Ansari MJ and Ahmadi SH (2012) Prosthetic tricuspid valve thrombosis: three case reports and literature review. J Tehran Heart Cent. 7:147-155.
25. Gündüz S, Yesin M, Gürsoy MO, Kalçık M, Özkan M (2015) Management of Patients With Prosthetic Valve Thrombosis After Failed Thrombolytic Therapy. J Am Coll Cardiol. 66:875-876.
26. Gündüz S, Özkan M, Kalçik M, Gürsoy OM, Astarcioğlu MA, Karakoyun S, Aykan AÇ, Biteker M, Gökdeniz T, Kaya H, Yesin M, Duran NE, Sevinç D, Güneysu T (2015) Sixty-Four-Section Cardiac Computed Tomography in Mechanical Prosthetic Heart Valve Dysfunction: Thrombus or Pannus. Circ Cardiovasc Imaging. 8. pii: e003246.
27. Hariram V (2014) Percutaneous management of prosthetic valve thrombosis. Indian Heart J. 66:427-429.
28. Asmarats L, Houde C, Pasian S, Rodés-Cabau J (2018) Transcatheter valve-in-valve overexpansion for treating a large dysfunctional tricuspid bioprosthesis. Interact Cardiovasc Thorac Surg. 26:527-528.
29. Songur CM, Simsek E, Ozen A, Kocabeyoglu S and Donmez TA (2014) Long term results comparing mechanical and biological prostheses in the tricuspid valve position: which valve types are better–mechanical or biological prostheses? Heart Lung Circ. 23:1175-178.